Chromosomal localization of PHOX2B during M‐phase is disrupted in disease‐associated mutants
Development, Growth & Differentiation · 2025
DOI: 10.1111/dgd.70001 ↗At a glance
Journal article in Development, Growth & Differentiation, 2025. Written by Yuki Sato and 8 co-authors. Institution: Department of Anatomy, Faculty of Medicine, Kansai Medical University, Osaka, Japan. Major MEDLINE topics: Homeodomain Proteins, Transcription Factors. Cited 1 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Kansai Medical University The Strategic Project for Proofreading and Submission Support of International Academic Papers, Japan Society for the Promotion of Science.
Abstract (original language)
In the M‐phase, the nuclear membrane is broken down, nucleosomes are condensed as mitotic chromosomes, and transcription factors are generally known to be dislocated from their recognition sequences and dispersed to the cytoplasm. However, some transcription factors have recently been reported to remain on mitotic chromosomes and facilitate the rapid re‐activation of the target genes in early G1‐phase. Paired‐like homeobox 2B (PHOX2B) is a transcription factor exhibiting chromosomal localization during M‐phase. PHOX2B mutations are associated with congenital central hypoventilation syndrome, Hirschsprung disease, and neuroblastoma. In this study, we investigated PHOX2B chromosomal localization during M‐phase through immunostaining and fluorescence recovery after photobleaching analysis to determine whether the chromosomal localization of disease‐associated PHOX2B mutants is altered during M‐phase. Missense mutations in the homeodomain and the frameshift mutation in the C‐terminal domain disrupted the chromosomal localization of PHOX2B in M‐phase, leading to its dispersion in the cell. Furthermore, a PHOX2B mutant with polyalanine expansion showed a line‐shaped localization to the restricted region of mitotic chromosomes. Our findings suggest an association between the disease‐associated mutations and defective chromosomal localization of transcription factors during M‐phase. Further investigations of PHOX2B chromosomal localization during M‐phase could reveal pathogenic mechanisms of such diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Anatomy, Faculty of Medicine, Kansai Medical University, Osaka, Japan.
- Faculty of Nursing, Kansai Medical University, Osaka, Japan.
ORCID profiles: Yuki Sato, Shinichi Hayashi, Souichi Oe, Taro Koike, Yousuke Nakano, Ryohei Seki-Omura, Hikaru Iwashita, Yukie Hirahara, Masaaki Kitada
Funding
- Kansai Medical University The Strategic Project for Proofreading and Submission Support of International Academic Papers
- Japan Society for the Promotion of Science
Cite
APA
Sato, Y., Hayashi, S., Oe, S., Koike, T., Nakano, Y., Seki-Omura, R., Iwashita, H., Hirahara, Y., & Kitada, M. (2025). Chromosomal localization of PHOX2B during M‐phase is disrupted in disease‐associated mutants. Development, Growth & Differentiation. https://doi.org/10.1111/dgd.70001
Vancouver
Sato Y, Hayashi S, Oe S, Koike T, Nakano Y, Seki-Omura R, et al. Chromosomal localization of PHOX2B during M‐phase is disrupted in disease‐associated mutants. Development, Growth & Differentiation. 2025. doi:10.1111/dgd.70001
BibTeX
@article{Sato2025,
author = {Sato, Yuki and Hayashi, Shinichi and Oe, Souichi and Koike, Taro and Nakano, Yousuke and Seki-Omura, Ryohei and Iwashita, Hikaru and Hirahara, Yukie and Kitada, Masaaki},
title = {Chromosomal localization of PHOX2B during M‐phase is disrupted in disease‐associated mutants},
journal = {Development, Growth & Differentiation},
year = {2025},
doi = {10.1111/dgd.70001}
}
EUVIMED